tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DAWN Stock Latest News

Day One Biopharmaceuticals initiated with an Overweight at Piper Sandler
The FlyDay One Biopharmaceuticals initiated with an Overweight at Piper Sandler
10d ago
DAWN
Day One Biopharmaceuticals initiated with an Overweight at Piper Sandler
PremiumThe Fly
Day One Biopharmaceuticals initiated with an Overweight at Piper Sandler
11d ago
DAWN
Promising Growth and Stability Drive Buy Rating for Day One Biopharmaceuticals
PremiumRatings
Promising Growth and Stability Drive Buy Rating for Day One Biopharmaceuticals
18d ago
DAWN
Day One Biopharma’s Earnings Call Highlights Growth and Strategy
PremiumCompany Announcements
Day One Biopharma’s Earnings Call Highlights Growth and Strategy
23d ago
DAWN
Promising Growth and Strategic Innovation Drive Buy Rating for Day One Biopharmaceuticals
PremiumRatings
Promising Growth and Strategic Innovation Drive Buy Rating for Day One Biopharmaceuticals
23d ago
DAWN
Buy Rating for Day One Biopharmaceuticals Amid Promising Future Catalysts Despite Current Challenges
PremiumRatingsBuy Rating for Day One Biopharmaceuticals Amid Promising Future Catalysts Despite Current Challenges
23d ago
DAWN
Day One Biopharmaceuticals price target lowered to $17 from $20 at BofA
Premium
The Fly
Day One Biopharmaceuticals price target lowered to $17 from $20 at BofA
23d ago
DAWN
Day One price target lowered to $25 from $36 at H.C. Wainwright
Premium
The Fly
Day One price target lowered to $25 from $36 at H.C. Wainwright
23d ago
DAWN
Day One Biopharma Reports Strong Q2 2025 Growth
PremiumCompany Announcements
Day One Biopharma Reports Strong Q2 2025 Growth
24d ago
DAWN
Day One Biopharmaceuticals Reports Strong Q2 2025 Results
PremiumCompany Announcements
Day One Biopharmaceuticals Reports Strong Q2 2025 Results
24d ago
8K
DAWN
Day One Biopharmaceuticals reports Q2 EPS (29c), consensus (34c)
PremiumThe Fly
Day One Biopharmaceuticals reports Q2 EPS (29c), consensus (34c)
24d ago
DAWN
Day One Biopharmaceuticals appoints Michael Vasconcelles as Head of R&D
PremiumThe Fly
Day One Biopharmaceuticals appoints Michael Vasconcelles as Head of R&D
3M ago
DAWN
Day One Biopharmaceuticals Approves Key Proposals at Annual Meeting
PremiumCompany AnnouncementsDay One Biopharmaceuticals Approves Key Proposals at Annual Meeting
3M ago
8K
DAWN
Positive Outlook for Day One Biopharmaceuticals’ Ojemda: A Promising First-Line Treatment for Pediatric Glioma
Premium
Ratings
Positive Outlook for Day One Biopharmaceuticals’ Ojemda: A Promising First-Line Treatment for Pediatric Glioma
3M ago
DAWN
Buy Rating for Day One Biopharmaceuticals Driven by FDA Approval and Strong Market Potential
Premium
Ratings
Buy Rating for Day One Biopharmaceuticals Driven by FDA Approval and Strong Market Potential
3M ago
DAWN
Promising Future for Day One Biopharmaceuticals: Buy Rating on Ojemda’s Potential in Pediatric Brain Tumors
PremiumRatings
Promising Future for Day One Biopharmaceuticals: Buy Rating on Ojemda’s Potential in Pediatric Brain Tumors
3M ago
DAWN
Day One Biopharma’s Earnings Call Highlights Growth
PremiumCompany Announcements
Day One Biopharma’s Earnings Call Highlights Growth
4M ago
DAWN
Day One price target lowered to $26 from $30 at JonesResearch
PremiumThe Fly
Day One price target lowered to $26 from $30 at JonesResearch
4M ago
DAWN
Day One Biopharmaceuticals: A Compelling Buy Amidst Growth Potential and Strong Financial Position
PremiumRatings
Day One Biopharmaceuticals: A Compelling Buy Amidst Growth Potential and Strong Financial Position
4M ago
DAWN
Positive Outlook for Day One Biopharmaceuticals Despite Seasonal Challenges, Buy Rating Reaffirmed
PremiumRatingsPositive Outlook for Day One Biopharmaceuticals Despite Seasonal Challenges, Buy Rating Reaffirmed
4M ago
DAWN
Optimistic Outlook for Day One Biopharmaceuticals: Buy Rating Affirmed Amid Promising Ojemda Launch and Growth Potential
Premium
Ratings
Optimistic Outlook for Day One Biopharmaceuticals: Buy Rating Affirmed Amid Promising Ojemda Launch and Growth Potential
4M ago
DAWN
Buy Rating Affirmed for Day One Biopharmaceuticals: Promising Growth and Strategic Advancements
Premium
Ratings
Buy Rating Affirmed for Day One Biopharmaceuticals: Promising Growth and Strategic Advancements
4M ago
DAWN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >